E-Pharmacy Market in India 2021
In the recent years, e-pharmacy emerged as a better and more convenient approach that addressed the issues faced by the consumers and provided superior customer solutions over its physical counterparts. The e-pharmacy market was valued at INR 50.71 Bn in 2020. It is estimated to reach INR 458.14 Bn by 2026, expanding at a compound annual growth rate (CAGR) of ~44.99% during the 2021 – 2026 period.
Segment insights:
The market is categorized into two segments – chronic and acute therapy. In 2020, the chronic therapy segment dominated the market, accounting for 63.42% of the revenue. It is expected to dominate during the forecast period. However, its market share is likely to decline to 53.92% in 2026. The acute therapy segment is forecast to achieve promising growth during the forecast period. Its market share is anticipated to increase from 36.58% in 2020 to 46.08% in 2026, expanding at a CAGR of 50.56% during the 2021 – 2026 period.
Consumers with chronic conditions require long-term treatment, and thus, have repeated need for medication. People prefer e-pharmacy platforms, owing to the availability of a wide range of medicines at discounted prices. Customers may increasingly prefer these platforms for managing acute ailments such as common cold in the coming years.
Market insights:
The market has gained traction in recent years; increased penetration of the internet and smartphones, prevalence of lifestyle disease, and government initiatives have fuelled its growth. Discounts impacting profitability, data breaches and cybercrime, pharmacovigilance and bottleneck in supply network are a few of the factors that impedes its development.
Several start-ups, leading e-commerce companies, and traditional brick-and-mortar stores have entered the market attracted by its immense growth potential. In 2020, it witnessed the entry of major players such as Amazon, Reliance, and Tata.
In June 10, 2021, Tata Digital bought the key e-pharmacy player, 1mg. In the same month, PharmEasy acquired 66% stake in Thyrocare.
Impact of COVID-19:
The COVID-19 pandemic has disrupted the nationwide healthcare system and severely impacted online pharmacy. With the onset of the second wave, e-commerce platforms such as e-pharmacy has developed more in this situation. The market witnessed huge spike in sales during the second wave. It is expected to rise again when the third wave hits. Creating alliance with local pharmacy retailers enabled key players to address the gaps in their last-mile deliveries. Also, measures such as collaborating with e-payment platforms were taken to ensure safe and convenient transactions thereby attracting cashbacks, discounts and COD options in remote areas as well which helped in getting attention of customers from rural areas as well.
Companies covered
Segment insights:
The market is categorized into two segments – chronic and acute therapy. In 2020, the chronic therapy segment dominated the market, accounting for 63.42% of the revenue. It is expected to dominate during the forecast period. However, its market share is likely to decline to 53.92% in 2026. The acute therapy segment is forecast to achieve promising growth during the forecast period. Its market share is anticipated to increase from 36.58% in 2020 to 46.08% in 2026, expanding at a CAGR of 50.56% during the 2021 – 2026 period.
Consumers with chronic conditions require long-term treatment, and thus, have repeated need for medication. People prefer e-pharmacy platforms, owing to the availability of a wide range of medicines at discounted prices. Customers may increasingly prefer these platforms for managing acute ailments such as common cold in the coming years.
Market insights:
The market has gained traction in recent years; increased penetration of the internet and smartphones, prevalence of lifestyle disease, and government initiatives have fuelled its growth. Discounts impacting profitability, data breaches and cybercrime, pharmacovigilance and bottleneck in supply network are a few of the factors that impedes its development.
Several start-ups, leading e-commerce companies, and traditional brick-and-mortar stores have entered the market attracted by its immense growth potential. In 2020, it witnessed the entry of major players such as Amazon, Reliance, and Tata.
In June 10, 2021, Tata Digital bought the key e-pharmacy player, 1mg. In the same month, PharmEasy acquired 66% stake in Thyrocare.
Impact of COVID-19:
The COVID-19 pandemic has disrupted the nationwide healthcare system and severely impacted online pharmacy. With the onset of the second wave, e-commerce platforms such as e-pharmacy has developed more in this situation. The market witnessed huge spike in sales during the second wave. It is expected to rise again when the third wave hits. Creating alliance with local pharmacy retailers enabled key players to address the gaps in their last-mile deliveries. Also, measures such as collaborating with e-payment platforms were taken to ensure safe and convenient transactions thereby attracting cashbacks, discounts and COD options in remote areas as well which helped in getting attention of customers from rural areas as well.
Companies covered
- 91Streets Media Technologies Private Limited (PharmEasy)
- 1mg
- MedPlus Health Services Private Limited
- Netmeds Marketplace Limited
- Medlife
- Apollo Pharmacies Pvt. Limited
- Healthkart
- mCHEMIST Global Private Limited
- Medsonway Solutions Pvt Ltd
- Truemeds
CHAPTER 1: EXECUTIVE SUMMARY
CHAPTER 2: SOCIO-ECONOMIC INDICATORS
CHAPTER 3: INTRODUCTION
3.1. Market definition and structure
3.2. Stakeholders in ecosystem
3.2.1. Value proposition
3.2.2. Concerns
CHAPTER 4: MARKET OVERVIEW
4.1. India e-pharmacy market overview
4.1.1. Market size and growth forecast (2020 – 2026e)
4.2. Number of households using e-pharmacy (2020 – 2026e)
4.3. Market snapshot
CHAPTER 5: MARKET SEGMENTATION
5.1. E-pharmacy market in India – Segmentation based on type
5.1.1. India e-pharmacy market share (%) (2020 – 2026e)
5.1.2. E-pharmacy market in India for chronic therapy segment (2020 – 2026e)
5.1.3. E-pharmacy market in India for acute therapy segment (2020 – 2026e)
CHAPTER 6: BUSINESS MODEL
6.1. Business model
CHAPTER 7: MERGERS AND ACQUISITIONS
7.1. Mergers and acquisitions
CHAPTER 8: TECHNOLOGY LANDSCAPE
8.1. Key technologies
8.2. Tech-stack of key companies
CHAPTER 9: IMPACT OF COVID-19
9.1. Impact on various stakeholders
9.1.1. Consumers
9.1.2. E-pharmacy companies
9.1.3. Government
9.2. Changes ahead
CHAPTER 10: MARKET INFLUENCERS
10.1. Market drivers
10.2. Market challenges
CHAPTER 11: FUNDING
11.1. Funding
CHAPTER 12: COMPANY BENCHMARKING
12.1. Player benchmarking
12.2. Website benchmarking
CHAPTER 13: COMPETITIVE LANDSCAPE
• 13.1. 91Streets Media Technologies Private Limited (PharmEasy)
13.1.1. Company information
13.1.2. Business description
13.1.3. Products/Services
13.1.4. Key people
13.2. 1mg
13.3. MedPlus Health Services Private Limited
13.4. NetMeds Marketplace Limited
13.5. Medlife
13.6. Apollo Pharmacies Pvt. Limited
13.7. Healthkart
13.8. mCHEMIST Global Private Limited
13.9. Medsonway Solutions Pvt Ltd
13.10. Truemeds
CHAPTER 14: RECENT DEVELOPMENTS
14.1. Recent developments
CHAPTER 15: APPENDIX
15.1. Research methodology
15.2. About Netscribes
15.3. Disclaimer
CHAPTER 2: SOCIO-ECONOMIC INDICATORS
CHAPTER 3: INTRODUCTION
3.1. Market definition and structure
3.2. Stakeholders in ecosystem
3.2.1. Value proposition
3.2.2. Concerns
CHAPTER 4: MARKET OVERVIEW
4.1. India e-pharmacy market overview
4.1.1. Market size and growth forecast (2020 – 2026e)
4.2. Number of households using e-pharmacy (2020 – 2026e)
4.3. Market snapshot
CHAPTER 5: MARKET SEGMENTATION
5.1. E-pharmacy market in India – Segmentation based on type
5.1.1. India e-pharmacy market share (%) (2020 – 2026e)
5.1.2. E-pharmacy market in India for chronic therapy segment (2020 – 2026e)
5.1.3. E-pharmacy market in India for acute therapy segment (2020 – 2026e)
CHAPTER 6: BUSINESS MODEL
6.1. Business model
CHAPTER 7: MERGERS AND ACQUISITIONS
7.1. Mergers and acquisitions
CHAPTER 8: TECHNOLOGY LANDSCAPE
8.1. Key technologies
8.2. Tech-stack of key companies
CHAPTER 9: IMPACT OF COVID-19
9.1. Impact on various stakeholders
9.1.1. Consumers
9.1.2. E-pharmacy companies
9.1.3. Government
9.2. Changes ahead
CHAPTER 10: MARKET INFLUENCERS
10.1. Market drivers
10.2. Market challenges
CHAPTER 11: FUNDING
11.1. Funding
CHAPTER 12: COMPANY BENCHMARKING
12.1. Player benchmarking
12.2. Website benchmarking
CHAPTER 13: COMPETITIVE LANDSCAPE
• 13.1. 91Streets Media Technologies Private Limited (PharmEasy)
13.1.1. Company information
13.1.2. Business description
13.1.3. Products/Services
13.1.4. Key people
13.2. 1mg
13.3. MedPlus Health Services Private Limited
13.4. NetMeds Marketplace Limited
13.5. Medlife
13.6. Apollo Pharmacies Pvt. Limited
13.7. Healthkart
13.8. mCHEMIST Global Private Limited
13.9. Medsonway Solutions Pvt Ltd
13.10. Truemeds
CHAPTER 14: RECENT DEVELOPMENTS
14.1. Recent developments
CHAPTER 15: APPENDIX
15.1. Research methodology
15.2. About Netscribes
15.3. Disclaimer
